Exclusive: Mikael Dolsten joins gene editing startup's board and eyes 'opportunities' with new FDA leaders

Ryan Cross

Senior Science Correspondent

Mikael Dolsten, Pfizer’s former chief scientific officer who led the company’s Covid-19 vaccine development, has joined the board of Arbor Biotechnologies, a gene editing startup …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Exclusive: Mikael Dolsten joins gene editing startup's board and eyes 'opportunities' with new FDA leaders

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say

RFK Jr. says he did not commit to upholding ACIP roster to secure Cassidy’s backing

Nektar's mid-stage eczema data deliver key win in bid for company turnaround

RFK Jr. pledges to keep the US at the center of the biotech 'revolution'

Former FDA scientist and psychedelics researcher hired as CDER deputy director

Digital Twins in GMP Manufacturing: Shaping the Future of CPV with Aizon

Ex­clu­sive: Mikael Dol­sten joins gene edit­ing star­tup's board and eyes 'op­por­tu­ni­ties' with new FDA lead­ers

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Ex­clu­sive: FDA's Makary sought re­jec­tion of KalVista’s drug in an un­usu­al move by com­mis­sion­er, sources say

RFK Jr. says he did not com­mit to up­hold­ing ACIP ros­ter to se­cure Cas­sidy’s back­ing

Nek­tar's mid-stage eczema da­ta de­liv­er key win in bid for com­pa­ny turn­around

RFK Jr. pledges to keep the US at the cen­ter of the biotech 'rev­o­lu­tion'

For­mer FDA sci­en­tist and psy­che­delics re­searcher hired as CDER deputy di­rec­tor

Dig­i­tal Twins in GMP Man­u­fac­tur­ing: Shap­ing the Fu­ture of CPV with Aizon

Exclusive: Mikael Dolsten joins gene editing startup's board and eyes 'opportunities' with new FDA leaders

Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say

RFK Jr. says he did not commit to upholding ACIP roster to secure Cassidy’s backing

Nektar's mid-stage eczema data deliver key win in bid for company turnaround

RFK Jr. pledges to keep the US at the center of the biotech 'revolution'

Former FDA scientist and psychedelics researcher hired as CDER deputy director

Digital Twins in GMP Manufacturing: Shaping the Future of CPV with Aizon